Numerous long noncoding RNAs (lncRNAs) have been identified as powerful regulators of
human diseases. The lncRNA FOXD3-AS1 is a novel lncRNA that was recently shown to …

Abstract Objectives Long non-coding RNAs (lncRNAs) are a group of noncoding RNAs with
length larger than 200 nucleotides. LncRNAs have limited or no protein-coding capacity …

Long noncoding RNAs (lncRNAs) are vital mediators involved in cancer progression.
Previous studies confirmed that FOXD2 adjacent opposite strand RNA 1 (FOXD2‐AS1) is …

OBJECTIVE: A growing number of long noncoding RNAs (lncRNAs) are emerging as new
modulators in cancer origination and progression. However, the functions and molecular …

Background and aims: Long non-coding RNA (lncRNA) FOXD2 adjacent opposite strand
RNA 1 (FOXD2-AS1) is aberrantly expressed in various cancers and associated with cancer …

For women, breast cancer is the most commonly diagnosed cancer and the leading cause of
women deaths due to cancer. In recent years, increasing long noncoding RNA (lncRNA) has …

Long non‑coding RNA (lncRNA) is essential to the development and progression of
malignant human cancer. Growing evidence suggests that the lncRNA forkhead box D3 …

Abstract Long noncoding RNA (lncRNA) FOXC2-AS1 has been reported to act as an
oncogene in multiple human cancers. However, the clinical significance, functional role and …

Aims Altered activities of long noncoding RNAs (lncRNAs) have been associated with
cancer development, and lncRNA FOXD1‐AS1 (FOXD1‐AS1) is the antisense transcript of …

Increasing amounts of long noncoding RNAs (lncRNAs) have been shown to be involved in
the development of cancer. Recently, aberrant expression of the lncRNA forkhead box D2 …